Article
Allelic variants of the thiopurine methyltransferase (TPMT) gene in the Colombian population.
Methods and findings in experimental and clinical pharmacology - 1 Jan 2000
Isaza C, Henao J, López A M, Cacabelos R
Abstract excerpt
Thiopurine methyltransferase (TPMT) catalyzes the inactivation of thiopurine drugs (mercaptopurine, thioguanine and azathioprine) used to treat acute lymphoblastic leukemia, autoimmune diseases and recipients of transplanted organs. No endogenous substrates for this enzyme are known. The TPMT polymorphism is a major determinant of individual differences in the toxicity or therapeutic efficacy of these drugs. The...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
